1. Home
  2. GPUS vs DRMA Comparison

GPUS vs DRMA Comparison

Compare GPUS & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPUS
  • DRMA
  • Stock Information
  • Founded
  • GPUS 1969
  • DRMA 2014
  • Country
  • GPUS United States
  • DRMA United States
  • Employees
  • GPUS N/A
  • DRMA N/A
  • Industry
  • GPUS
  • DRMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • GPUS
  • DRMA Health Care
  • Exchange
  • GPUS NYSE
  • DRMA Nasdaq
  • Market Cap
  • GPUS 4.1M
  • DRMA 4.5M
  • IPO Year
  • GPUS 1996
  • DRMA 2021
  • Fundamental
  • Price
  • GPUS $2.25
  • DRMA $0.73
  • Analyst Decision
  • GPUS
  • DRMA Strong Buy
  • Analyst Count
  • GPUS 0
  • DRMA 1
  • Target Price
  • GPUS N/A
  • DRMA $6.00
  • AVG Volume (30 Days)
  • GPUS 50.9K
  • DRMA 4.3M
  • Earning Date
  • GPUS 05-19-2025
  • DRMA 05-14-2025
  • Dividend Yield
  • GPUS N/A
  • DRMA N/A
  • EPS Growth
  • GPUS N/A
  • DRMA N/A
  • EPS
  • GPUS N/A
  • DRMA N/A
  • Revenue
  • GPUS $106,662,000.00
  • DRMA N/A
  • Revenue This Year
  • GPUS N/A
  • DRMA N/A
  • Revenue Next Year
  • GPUS N/A
  • DRMA N/A
  • P/E Ratio
  • GPUS N/A
  • DRMA N/A
  • Revenue Growth
  • GPUS 3.50
  • DRMA N/A
  • 52 Week Low
  • GPUS $2.14
  • DRMA $0.70
  • 52 Week High
  • GPUS $20.30
  • DRMA $6.17
  • Technical
  • Relative Strength Index (RSI)
  • GPUS N/A
  • DRMA 28.13
  • Support Level
  • GPUS N/A
  • DRMA $0.72
  • Resistance Level
  • GPUS N/A
  • DRMA $0.89
  • Average True Range (ATR)
  • GPUS 0.00
  • DRMA 0.10
  • MACD
  • GPUS 0.00
  • DRMA -0.03
  • Stochastic Oscillator
  • GPUS 0.00
  • DRMA 5.92

About GPUS HYPERSCALE DATA INC

Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has eight reportable segments: Energy and Infrastructure; Technology and Finance; SMC; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Disruptive.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

Share on Social Networks: